Skip to content

Study · Not a test of the peptide alone · 1976

1 result

Effect of intravenous glucagon on urinary catecholamine excretion in normal man.

Young JB, Landsberg L, Knopp RH

Metabolism: clinical and experimental1 Feb 1976Cited by 3 (Europe PMC)

PMID1250159 (opens in a new tab)DOI10.1016/0026-0495(76)90054-8 (opens in a new tab)PepBankPUB-01250159
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Glucagon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Glucagon.

  1. 01HumanNot a test of Glucagon aloneNon-randomized trialActivity measurement

    In normal subjects, urinary norepinephrine did not rise after glucagon or the other tests.

    In plain wordsIn normal subjects, urinary norepinephrine did not increase after glucagon or the other tests.

    Peptide
    Glucagon
    Outcome
    No significant changeUrinary norepinephrine
    Study

    n: not reported in source

    Outcome group
    Catecholamine Response · Endocrine and hormones

    Source sentences

    Summary
    No rise in urinary norepinephrine was detected in any test.
    2 context sentences
    Summary · context
    We have evaluated intravenous glucagon as pharmacologic stimulus to adrenal catecholamine secretion in normal human subjects.
    Summary · context
    Urinary epinephrine and norepinephrine were measured at two hourly intervals before and after the intravenous injection of saline, 4 mg glucagon, or 0.1 mu/kg crystalline insulin.

    In this study, Glucagon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Glucagon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.